Zeb2 is substantially associated with the progression, malignancy, and prognosis of gastrointestinal malignancies [39,40], and Zeb2 can affect the EMT process of cancers through the Wnt/β-Catenin pathway [41]. The gene discussed is ZEB2; the disease is cancer.